+ Translate

Efficacy of ivermectin treatment of Loa loa filariasis patients without microfilaraemias

, : Efficacy of ivermectin treatment of Loa loa filariasis patients without microfilaraemias. Annals of Tropical Medicine and Parasitology 88(1): 93-94

(PDF 0-2 workdays service)

Order PDF Full Text


Click here to order any other PDF Full Text

Accession: 002367653

PMID: 8192523

PDF Full Text: Submit

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:

Other references

Dev, G; Dhillon, Ns; Brar, Js, 1984: Determination of fertiliser nitrogen dose for rice on basis of marginal returns. Fertiliser marketing news 15(7): 1-3

Eidson, C.S.; Kleven, S.H.; Anderson, D.P., 1973: Efficacy of cellfree and cell-associated herpesvirus of turkeys vaccines in progeny from vaccinated parental flocks. Parental immunity did not interfere with the cell-associated herpesvirus of turkeys (HVT) vaccine, but did interfere with the cellfree HVT vaccine, especially when the parent flocks were inoculated more than once with the cell-associated HVT vacci...

Ohkawara, Sou; Asanuma, Narito; Hino, Tsuneo, 2003: Regulator protein that potentially triggers the transcription of the H+-ATPase operon in a ruminal bacterium, Streptococcus bovis. In order to seek regulator proteins that are involved in the transcription of the H+-ATPase operon (atp) in Streptococcus bovis, a transcriptional promoter region of the atp was identified. DNase I footprinting revealed the presence of S. bovis ce...

Bundza, A; Stead, Rh, 1986: Medullary hyroid carcinoma in two cows. Veterinary pathology 23(1): 90-92

Ren, H.; Tian, L.; Gu, Q.; Zhu, W., 2006: Secalonic acid D; A cytotoxic constituent from marine lichen-derived fungus Gliocladium sp. T31. Secalonic acid D (SAD) was isolated as the major secondary metabolite of the marine lichen-derived fungus Gliocladium sp. T31. Its structure was established on the basic of physicochemical and spectroscopic data. This is the first report on the is...

Petrali, J. P.; Mills, K. R., 1999: Microwave-assisted immunoelectron microscopy of skin: Localization of laminin, type IV collagen, and bullous pemphigoid antigen. Chemical fixatives and conventional fixation times used for standardized preservation of tissues can result in serious alterations in morphology as a consequence of solubilization and conformational changes of proteins and lipids. These untoward c...

Leopold D.A.; Lagoe R.J., 1986: Patterns of otolaryngologic surgery utilization in syracuse new york usa. Utilization of otolaryngologic surgical procedures performed in Syracuse, NY, during 1983 and 1984 was evaluated. Both inpatient and outpatient procedures were included; classification was according to diagnosis related groups. The system-wide por...

Erlandsson R.; Zabarovsky E.R.; Allikmets R.L.; Boldog F.; Kashuba V.I.; Sumegi J.; Klein G., 1991: Acylpeptide hydrolase expression is reduced in renal cell carcinoma. Cytogenetics & Cell Genetics 58(1-4): 1876

Cooney, E.L.; McElrath, M.J.; Corey, L.; Hu, S.L.; Collier, A.C.; Arditti, D.; Hoffman, M.; Coombs, R.W.; Smith, G.E.; Greenberg, P.D., 1993: Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein. Transmission studies have suggested that an optimal human immunodeficiency virus type 1 (HIV-1) vaccine should induce both neutralizing antibodies and cytolytic T cells to eliminate free virus and infected cells. A phase I trial in healthy HIV-1-s...

McAtee, J.J.; Dodson, J.W.; Dowdell, S.E.; Girard, G.R.; Goodman, K.B.; Hilfiker, M.A.; Sehon, C.A.; Sha, D.; Wang, G.Z.; Wang, N.; Viet, A.Q.; Zhang, D.; Aiyar, N.V.; Behm, D.J.; Carballo, L.H.; Evans, C.A.; Fries, H.E.; Nagilla, R.; Roethke, T.J.; Xu, X.; Yuan, C.C.K.; Douglas, S.A.; Neeb, M.J., 2008: Development of potent and selective small-molecule human Urotensin-II antagonists. This work describes the development of potent and selective human Urotensin-II receptor antagonists starting from lead compound 1, (3,4-dichlorophenyl) methyl{2-oxo-2-[3-phenyl-2-(1-pyrrolidinylmethyl)1-piperidinyl]ethyl}amine. Several problems r...